(8744) Trilogy Evo
Payments companies reported to CMS as associated with (8744) Trilogy Evo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (8744) Trilogy Evo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (8744) Trilogy Evo
These are the largest totals companies reported as associated with (8744) Trilogy Evo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Hiatt | Houston, TX | Pediatric Pulmonology | $15,909.15 |
| Luqi Chi | Saint Louis, MO | Neurology (Psychiatry & Neurology) | $13,431.00 |
| John Hansen-Flaschen | Philadelphia, PA | Pulmonary Disease | $12,696.72 |
| Jose Yataco | Jacksonville, FL | Pulmonary Disease | $59.87 |
| Abdallah Kafrouni | Jacksonville, FL | Critical Care Medicine (Internal Medicine) | $59.86 |
| Mario Kinsella | Erie, PA | Pulmonary Disease | $48.30 |
| Olusola Oguntolu | Nashville, TN | Pulmonary Disease | $42.26 |
| Mollie Mcguire | Johnstown, PA | Primary Care | $28.69 |
| Lana Jeradeh Boursoulian | Nashville, TN | Sleep Medicine (Psychiatry & Neurology) | $25.88 |
| Kelvin Panesar | Scottsdale, AZ | Pediatric Pulmonology | $23.14 |
Prescribed (8744) Trilogy Evo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.